cas 2756-85-6|| where to buy 1-Aminocyclohexane-1-carboxylic acid

Nom du produit:1-Aminocyclohexane-1-carboxylic acid

IUPAC Name:1-aminocyclohexane-1-carboxylic acid

Unité d'emballage	Stock disponible	Prix($)
CM203211-25g	in stock	ȡƥ
CM203211-100g	in stock	Ǒǫȯ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2756-85-6 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:2756-85-6; Formule moléculaire:C7H13NO2; Point de fusion:-; Code SMILES:O=C(C1(N)CCCCC1)O; Densité:

: Numéro de catalogue:CM203211; Poids moléculaire:143.19; Point d'ébullition:272.3±23.0°C at 760 mmHg; N° Mdl:MFCD00001487; Stockage:Store at 2-8°C.

: Amino Acids and Peptides; Amino acids are organic compounds containing a basic amino group and an acidic carboxyl group. Because amino acids contain both amino and carboxyl groups, they can be polymerized in an end-to-end manner, removing a molecule of water to form a covalent amide bond or peptide bond. Many amino acids are linked together end to end to form a polypeptide. Amino acids and peptides are important components in the fields of medicine and life sciences.; amino acids wholesale; if you are finding amino acids wholesaler in china, we will be your best choose! We have our own factory, so we can give you a cheap price!

: Cyclohexanes; Cyclohexane is an organic compound with a chemical formula C6H12. It is a colorless liquid with a pungent odor, insoluble in water, and soluble in most organic solvents such as ethanol, ether, benzene, and acetone. Cyclohexyl fragments are a common structure in both natural and synthetic drugs. It can be used as both core structure and part of achiral side chain.

: INX-315; Incyclix Bio announces FDA clearance of investigational new drug application for INX-315 in patients with advanced or metastatic cancer. INX-315 is a novel, potent and selective inhibitor of Cyclin-dependent kinase 2 (CDK2) with compelling pre-clinical efficacy and safety data.
CDK2 is thought to play an important role in driving proliferation of certain cancers, including those harboring CCNE1 amplification and breast cancers that have acquired resistance to CDK4/6 inhibitors (CDK4/6i).